Mark L Weiss

Title: Mark L Weiss: Innovator in Canine Stem Cell Research and Peptide Hydrogels

Introduction

Mark L Weiss is a prominent inventor based in Manhattan, Kansas, known for his significant contributions to the fields of canine stem cell research and peptide hydrogels. With a total of 4 patents, his work has advanced the understanding and application of mesenchymal stromal cells and innovative hydrogel technologies.

Latest Patents

Weiss's latest patents include groundbreaking methods for the isolation, preservation, and expansion of canine umbilical cord mesenchymal stromal cells. These methods enhance the handling of isolated canine UC-MSCs, focusing on their expansion, cryopreservation, and improved post-thaw viability using adherent plates. Additionally, he has developed standardized methods and kits for characterizing these cells within a population. Another notable patent involves peptide hydrogels that feature a self-assembling, three-dimensional nanofiber matrix. This matrix, which comprises an amphiphilic peptide and optionally albumin, has diverse applications in tissue engineering, drug delivery, and cell storage.

Career Highlights

Mark L Weiss is affiliated with the Kansas State University Research Foundation, where he has made significant strides in his research. His innovative approaches have not only contributed to academic knowledge but also have practical implications in veterinary medicine and biotechnology.

Collaborations

Throughout his career, Weiss has collaborated with esteemed colleagues, including Duane Davis and Kathy E Mitchell. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Mark L Weiss stands out as a key figure in the realm of innovations related to canine stem cells and peptide hydrogels. His patents reflect a commitment to advancing scientific knowledge and practical applications in these fields.